Effects of a Resistance Physical Exercise Program in Multiple Myeloma Patients
NCT07253103 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2025-11-28
Summary
The goal of this clinical trial is to learn if physical exercise improves quality of life, frailty and mental health in patients with multiple myeloma. It will also learn about the safety and adherence of the program. The main questions it aims to answer are:
Does physical exercise improves quality of life in patients with multiple myeloma? Does physical exercise improves frailty and mental health in patients with multiple myeloma? Researchers will compare supervised physical exercise and home-based unsupervised physical exercise.
Participants will:
Participate in one of the exercise programs, supervised or home-based, for 12 weeks. They will be completely evaluated before and after the intervention.
Conditions
- Multiple Myeloma (MM)
- Exercise
- Cancer
Interventions
- OTHER
-
Supervised physical exercise
Participants will follow a supervised physical exercise program for 12 weeks.
- OTHER
-
Home-based physical exercise program
Participants will follow a home-based physical exercise program for 12 weeks.
Sponsors & Collaborators
-
University of Salamanca
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-02-01
- Primary Completion
- 2026-05-01
- Completion
- 2026-09-01
More Related Trials
-
Smoldering Myeloma High-Risk Patient Observation and Longitudinal Insight Trial
NCT06212323 ·Status: RECRUITING
-
A Study to Investigate the Relationship Between Duration of Treatment and Response in Patients With Multiple Myeloma (MM) or Systemic AL Amyloidosis Treated in Real-life Practice
NCT04659798 ·Status: COMPLETED
-
Therapeutic Research in Multiple Myeloma
NCT00572338 ·Status: COMPLETED
-
The Myeloma Pack: A Multi-Modality Educational Intervention Strategy to Engage Patients With Multiple Myeloma
NCT03777306 ·Status: COMPLETED ·Phase: NA
-
Consolidation Therapy With Bortezomib in Elderly Patients With Multiple Myeloma
NCT00416208 ·Status: COMPLETED ·Phase: PHASE3
-
Patient and Care Partner Experiences Living With Multiple Myeloma (PaCE-MM)
NCT05276622 ·Status: TERMINATED
-
Geriatric Assessments in Senior Adults With Multiple Myeloma
NCT01746030 ·Status: COMPLETED
-
Bortezomib, Melphalan, and Total-Body Irradiation Before Stem Cell Transplant in Treating Patients With Multiple Myeloma
NCT01936090 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of Molecular Remission by ASO-qPCR After Bortezomib-dexamethasone (Vel/Dex) Followed by ASCT
NCT00861250 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
S0833, Bortezomib, Thalidomide, Lenalidomide, Combination Chemotherapy, and Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma
NCT01055301 ·Status: WITHDRAWN ·Phase: PHASE2
-
Effect of AT7519M Alone and AT7519M Plus Bortezomib in Patients With Previously Treated Multiple Myeloma
NCT01183949 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Home Treatment With Carfilzomib in Patients With Multiple Myeloma
NCT05620238 ·Status: RECRUITING
-
A Study of Efficacy of Treatment With Bortezomib (in Combination With Doxorubicin and Dexamethasone) in Previously Untreated Patients With Multiple Myeloma
NCT00872521 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety, Tolerability and Efficacy Study of ACE-011 in Patients With Osteolytic Lesions of Multiple Myeloma
NCT00747123 ·Status: COMPLETED ·Phase: PHASE2
-
Impacts on Health Outcomes and Resources Utilization of Hospital-at-home for Elderly Patients With Multiple Myeloma
NCT03490084 ·Status: UNKNOWN
-
A Study of Bortezomib as Consolidation Therapy in Patients With Multiple Myeloma
NCT00416273 ·Status: COMPLETED ·Phase: PHASE3
-
First Line Treatment Trial in Multiple Myeloma, Finnish Myeloma Group- Multiple Myeloma 02
NCT01790737 ·Status: COMPLETED ·Phase: PHASE2
-
Stem Cell Transplant and Zoledronic Acid Improve Outcome in Previously Untreated Patients With Multiple Myeloma
NCT01234129 ·Status: COMPLETED
-
Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma
NCT05673083 ·Status: ACTIVE_NOT_RECRUITING
-
Follow-up of Patients With Multiple Myeloma in the West-Occitanie Region "Living With a Myeloma in West-Occitanie"
NCT04888039 ·Status: RECRUITING
-
Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies
NCT05136807 ·Status: RECRUITING
-
Bortezomib Before Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma
NCT00995059 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Assessing the Impact of a Financial Navigation Program for Patients With Multiple Myeloma
NCT05448196 ·Status: COMPLETED ·Phase: NA
-
Bortezomib With Melphalan and Prednisone for Multiple Myeloma
NCT00734149 ·Status: COMPLETED ·Phase: PHASE2
-
Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma
NCT01849783 ·Status: COMPLETED ·Phase: PHASE2